Costs and quality of life in multiple sclerosis: A cross-sectional study in the United States

  • Kobelt G
  • Berg J
  • Atherly D
 et al. 
  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


To estimate current costs and quality of life (utility) of patients treated with disease modifying drugs {(DMDs)} in the United States, and to investigate the effect of disease severity on costs and utility.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • G Kobelt

  • J Berg

  • D Atherly

  • O Hadjimichael

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free